Disclosures for "A Novel Homozygous Variant in the CHRNE Gene in 2 Siblings with Congenital Myasthenic Syndrome")
-
Dr. Chan has nothing to disclose.
-
Ms. Emery has nothing to disclose.
-
Ermal Aliu has nothing to disclose.
-
Dr. Naik has nothing to disclose.
-
Dr. Paul has nothing to disclose.
-
Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Audentes Therapeutics. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC therapeutics. Dr. Kumar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avexis. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PTC therapeutics. The institution of Dr. Kumar has received research support from PTC therapeutics. The institution of Dr. Kumar has received research support from Sarepta Therapeutics. The institution of Dr. Kumar has received research support from Novartis. The institution of Dr. Kumar has received research support from Fibrogen . Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Draft Report Reviewer with PCORI Health Care Horizon Scanning System.